Detalhe da pesquisa
1.
Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin.
Clin Infect Dis
; 76(3): e910-e919, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861296
2.
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin.
Antimicrob Agents Chemother
; 67(11): e0043123, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850737
3.
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.
Antimicrob Agents Chemother
; 67(11): e0043023, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850738
4.
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Malar J
; 22(1): 165, 2023 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237283
5.
Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis.
J Clin Microbiol
; 59(3)2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33268538
6.
Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting.
J Transl Med
; 19(1): 76, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593378
7.
Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda.
medRxiv
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712186
8.
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda.
Afr J Lab Med
; 12(1): 1956, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36873289
9.
Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
J Int AIDS Soc
; 25(5): e25909, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543110